GPR52 是一种孤儿 G 蛋白偶联受体,选择性地在纹状体和皮质中表达,在伏隔核 (NAc) 中的表达水平最高。GPR52 在 NAc 和其他纹状体区域的选择性表达表明该受体在初级纹状体神经元和更广泛的皮质纹状体回路中发挥重要作用。此外,GPR52 仅与纹状体中棘状神经元 (MSN) 中的多巴胺 D2 受体共定位,在内侧前额皮质的神经元中表达较少。值得注意的是,在转基因小鼠中,GPR52 的过度表达显著降低了甲基苯丙胺诱导的运动能力,而 GPR52 基因敲除小鼠则表现出抗焦虑样表型。研究表明,GPR52 与 Gas/olf-G 蛋白偶联以激活腺苷酸环化酶并调节 cAMP 信号传导,并表现出高水平的组成活性。因此,GPR52 通过 cAMP 发出信号可以对抗纹状体中 D2 信号的活性,同时刺激额叶皮质中的 D1/N-甲基-d-天冬氨酸 (NMDA) 功能。因此,GPR52 可能成为治疗精神分裂症和物质滥用障碍 (SUD) 等精神疾病的有希望的新靶点。
GPR52 is an orphan G-protein-coupled receptor that is selectively expressed in the striatum and cortex with the highest level of expression in the nucleus accumbens (NAc). The selective expression of GPR52 in the NAc and other striatal regions suggests an important function for this receptor in primary striatal neurons and broader corticostriatal circuitry. Moreover, GPR52 is colocalized exclusively with dopamine D2 receptors in medium spiny neurons (MSNs) in the striatum and has lesser expression in neurons of the medial prefrontal cortex. Notably in transgenic mice, the overexpression of GPR52 significantly decreased methamphetamine-induced locomotion, while GPR52 knockout mice showed an anxiolytic-like phenotype. Studies have indicated that GPR52 couples to Gas/olf- G proteins to activate adenylyl cyclase and modulate cAMP signaling and displays high levels of constitutive activity. Thus, GPR52 signaling via cAMP could oppose activity of D2 signaling in the striatum while stimulating the D1/N-methyl-d-aspartate (NMDA) function in the frontal cortex. Therefore, GPR52 may serve as a promising novel target for psychiatric disorders including schizophrenia and substance use disorders (SUDs).
GPR52 antagonist-1(Compound 43)是一种 IC50 为 0.63 μM 的 GPR52 拮抗剂,通过靶向 GPR52 降低突变 huntingtin 蛋白水平,从而促进小鼠初级纹状体神经元存活。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号